ID26788A - Metoda pengobatan diabetes dengan menggunakan analogi peptida dari insulin - Google Patents

Metoda pengobatan diabetes dengan menggunakan analogi peptida dari insulin

Info

Publication number
ID26788A
ID26788A IDW20001917A ID20001917A ID26788A ID 26788 A ID26788 A ID 26788A ID W20001917 A IDW20001917 A ID W20001917A ID 20001917 A ID20001917 A ID 20001917A ID 26788 A ID26788 A ID 26788A
Authority
ID
Indonesia
Prior art keywords
analogy
insulin
peptides
diabetes treatment
diabetes
Prior art date
Application number
IDW20001917A
Other languages
English (en)
Inventor
Gaur Amitabh
Ling Nicholas
Paul J Conlon
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of ID26788A publication Critical patent/ID26788A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IDW20001917A 1998-02-23 1999-02-23 Metoda pengobatan diabetes dengan menggunakan analogi peptida dari insulin ID26788A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2815698A 1998-02-23 1998-02-23

Publications (1)

Publication Number Publication Date
ID26788A true ID26788A (id) 2001-02-08

Family

ID=21841884

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001917A ID26788A (id) 1998-02-23 1999-02-23 Metoda pengobatan diabetes dengan menggunakan analogi peptida dari insulin

Country Status (20)

Country Link
US (1) US6197926B1 (id)
EP (1) EP1056776A1 (id)
JP (1) JP2002504491A (id)
KR (1) KR20010041238A (id)
CN (1) CN1241942C (id)
AP (1) AP2000001888A0 (id)
AU (1) AU741037B2 (id)
BR (1) BR9908178A (id)
CA (1) CA2321929A1 (id)
EA (1) EA003944B1 (id)
HU (1) HUP0100928A3 (id)
ID (1) ID26788A (id)
IL (1) IL137904A0 (id)
NO (1) NO20004198L (id)
NZ (1) NZ506447A (id)
OA (1) OA11453A (id)
PL (1) PL342517A1 (id)
SK (1) SK12412000A3 (id)
TR (1) TR200003048T2 (id)
WO (1) WO1999042482A1 (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562942B1 (en) 1999-02-23 2003-05-13 Neurocrine Biosciences, Inc. Methods for treatment of diabetes using peptide analogues of insulin
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
US7462486B2 (en) * 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US7371385B2 (en) * 2000-05-12 2008-05-13 Oregon Health & Science University Method of treating immune pathologies with low dose estrogen
US20020103131A1 (en) * 2001-01-26 2002-08-01 Jacobson Jill D. Prevention of diabetes by administration of GnRH antagonists
US20070172453A1 (en) * 2002-08-30 2007-07-26 Vincent Geenen Tolerogenic approach for type 1 diabetes
US20040138116A1 (en) * 2002-08-30 2004-07-15 Vincent Geenen Tolerogenic approach for type 1 diabetes
ZA200502613B (en) 2002-10-10 2006-10-25 Yeda Res & Dev Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
EP1660110A2 (en) * 2003-06-02 2006-05-31 Mercia Pharma, Inc. Therapeutic vaccine compositions for the treatment of type 1 diabetes
US8053197B2 (en) * 2004-07-30 2011-11-08 Oregon Health & Science University Methods for detecting and treating autoimmune disorders
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
DE102008003566A1 (de) * 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
CA2713348C (en) 2008-01-30 2018-10-09 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
CN102245624B (zh) 2008-12-19 2016-08-10 印第安纳大学研究及科技有限公司 基于酰胺的胰岛素前药
EP2376520B1 (en) * 2008-12-19 2014-02-12 Indiana University Research&Technology Corporation Insulin analogs
PT2554183T (pt) 2009-11-13 2018-07-09 Sanofi Aventis Deutschland Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina
MY159565A (en) 2009-11-13 2017-01-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
US20110311536A1 (en) * 2010-06-11 2011-12-22 Dana-Farber Cancer Institute, Inc. Prevention of type 1 diabetes by treg vaccination with an insulin mimetope
CA2802485C (en) 2010-06-16 2019-09-17 Indiana University Research And Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
CA2803164C (en) 2010-06-24 2018-08-21 Indiana University Research And Technology Corporation Amide-based insulin prodrugs
LT2611458T (lt) 2010-08-30 2016-12-27 Sanofi-Aventis Deutschland Gmbh Ave0010 panaudojimas gaminant vaistą, skirtą 2 tipo cukrinio diabeto gydymui
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
UA113626C2 (xx) * 2011-06-02 2017-02-27 Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
CN104114183A (zh) 2011-12-20 2014-10-22 印第安纳大学研究及科技有限公司 用于治疗糖尿病的基于ctp的胰岛素类似物
EP3395358B1 (en) 2012-09-26 2019-11-06 Indiana University Research and Technology Corporation Insulin analog dimers
WO2014158900A1 (en) 2013-03-14 2014-10-02 Indiana University Research And Technology Corporation Insulin-incretin conjugates
US10232020B2 (en) 2014-09-24 2019-03-19 Indiana University Research And Technology Corporation Incretin-insulin conjugates
CN107001441A (zh) 2014-09-24 2017-08-01 印第安纳大学研究及科技有限公司 脂质化的基于酰胺的胰岛素前药
CR20170314A (es) 2014-12-12 2017-10-20 Sanofi Aventis Deutschland Formulación de relación fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN111925420B (zh) * 2019-12-11 2022-04-01 山东大学 一种多肽作为嗅觉受体Olfr109激动剂配体的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
US5594100A (en) * 1995-02-22 1997-01-14 Regents Of The University Of Colorado Epitope for prevention of type I diabetes
US6274549B1 (en) * 1995-06-30 2001-08-14 Novo Nordisk A/S Treatment of type 1 diabetes

Also Published As

Publication number Publication date
AU741037B2 (en) 2001-11-22
EP1056776A1 (en) 2000-12-06
IL137904A0 (en) 2001-10-31
WO1999042482A1 (en) 1999-08-26
CA2321929A1 (en) 1999-08-26
EA003944B1 (ru) 2003-10-30
SK12412000A3 (sk) 2002-05-09
PL342517A1 (en) 2001-06-18
CN1294597A (zh) 2001-05-09
EA200000872A1 (ru) 2001-02-26
AU2783199A (en) 1999-09-06
NZ506447A (en) 2002-11-26
CN1241942C (zh) 2006-02-15
AP2000001888A0 (en) 2000-09-30
OA11453A (en) 2003-12-08
KR20010041238A (ko) 2001-05-15
NO20004198L (no) 2000-10-20
BR9908178A (pt) 2002-01-15
NO20004198D0 (no) 2000-08-22
HUP0100928A2 (hu) 2001-08-28
HUP0100928A3 (en) 2001-11-28
US6197926B1 (en) 2001-03-06
JP2002504491A (ja) 2002-02-12
TR200003048T2 (tr) 2000-12-21

Similar Documents

Publication Publication Date Title
ID26788A (id) Metoda pengobatan diabetes dengan menggunakan analogi peptida dari insulin
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DE69817446D1 (de) Behandlung von diabetes
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1183020T3 (da) (3-trihalogenmethylphenoxy)(4-halogenphenyl) til behandling af insulinresistens og type 2-diabetes
DE60043305D1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO20022087L (no) Fremgangsmåte for behandling av diabetes
IL218909A0 (en) Treatment of diabetes
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DK1223997T3 (da) Medicinsk infusionssæt
NO20010982D0 (no) FremgangsmÕte for Õ administrere insulinotropiske peptider
EA200500098A1 (ru) Лекарственное средство и способ лечения патологического синдрома
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20013958L (no) Legemiddel for behandling av höyt blodtrykk
DK1206436T3 (da) Retinoider til behandling af emfysem
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
EP1183032A4 (en) METHOD FOR IMPROVING INSULIN EFFECT
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
DE60308045D1 (de) Pflanzenextrakte aus argyrolobium roseum zur behandlung von diabetes
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
IS6888A (is) Aðferð við meðferð sykursýki af gerð I
EP1435962A4 (en) TREATMENT OF DIABETES TYPE I
DK1154996T3 (da) Aminoacylaroylpyrroler til behandling af neuropatisk smerte
UA34041A (uk) Спосіб лікування цукрового діабету
DE69832075D1 (de) Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks